Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$200K Buy
+750
New +$203K 0.04% 172
2025
Q4
Sell
-750
Closed -$215K 186
2025
Q3
$215K Buy
+750
New +$201K 0.04% 179
2025
Q2
Sell
-1,000
Closed -$233K 190
2025
Q1
$233K Hold
1,000
0.06% 135
2024
Q4
$229K Hold
1,000
0.06% 135
2024
Q3
$223K Hold
1,000
0.07% 141
2024
Q2
$204K Hold
1,000
0.06% 141
2024
Q1
$218K Hold
1,000
0.07% 139
2023
Q4
$227K Hold
1,000
0.08% 134
2023
Q3
$201K Sell
1,000
-164
-14% -$34.6K 0.08% 135
2023
Q2
$241K Hold
1,164
0.09% 120
2023
Q1
$229K Sell
1,164
-15
-1% -$3.09K 0.11% 124
2022
Q4
$239K Buy
1,179
+15
+1% +$2.93K 0.12% 112
2022
Q3
$205K Hold
1,164
0.13% 115
2022
Q2
$234K Hold
1,164
0.14% 115
2022
Q1
$264K Hold
1,164
0.14% 110
2021
Q4
$314K Hold
1,164
0.16% 106
2021
Q3
$281K Hold
1,164
0.16% 109
2021
Q2
$276K Hold
1,164
0.16% 103
2021
Q1
$255K Hold
1,164
0.17% 99
2020
Q4
$204K Buy
+1,164
New +$201K 0.14% 106

Other funds holding LH

VeraBank's LH Position: Q1 2026 in Review

VeraBank opened a new position in Labcorp (LH) in Q1 2026: 750 shares worth $200K. The stake represents 0.04% of the portfolio and ranks #172 among its holdings. This is a return to the name: VeraBank previously reported a position in LH as recently as Q3 2025.

VeraBank first reported a position in LH in Q4 2020 and has held it in 20 quarters since. The position peaked at $314K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • VeraBank held 750 shares of Labcorp worth $200K as of Q1 2026.
  • Labcorp was a new VeraBank position in Q1 2026.
  • Labcorp made up 0.04% of VeraBank's portfolio in Q1 2026, its #172 holding.
  • VeraBank first reported a position in Labcorp in Q4 2020 and has held it in 20 quarters since.
  • VeraBank's Labcorp position peaked at $314K in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on VeraBank's 13F filing for Q1 2026, filed 12 May 2026.